

![]() |
143PD: Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: Results of the expanded SAKK19/09 trial |
|
Authors | ![]() | |
Published in | Journal of thoracic oncology. 2016, vol. 11, no. 4 Suppl, S120 | |
Identifiers | PMID: 27198283 | |
Full text | ||
Structures | ||
Research groups | Cancer du poumon et mésothéliome pleural malin (944) Groupe Mach Nicolas (oncologie) (654) | |
Citation (ISO format) | GAUTSCHI, Oliver et al. 143PD: Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: Results of the expanded SAKK19/09 trial. In: Journal of thoracic oncology, 2016, vol. 11, n° 4 Suppl, p. S120. doi: 10.1016/S1556-0864(16)30253-2 https://archive-ouverte.unige.ch/unige:93755 |